FDA Delays Enforcement on Some Flavored Vapes and Nicotine Pouches with Pending Applications
The agency announced it will not prioritize action against manufacturers with accepted applications that submitted sufficient public health data. The policy, issued without a draft for public comment, follows last week's authorization of two fruit-flavored vapes by Los Angeles-based Glas and comes as President Trump reportedly plans to fire Commissioner Marty Makary.
upi.comThe Food and Drug Administration announced a new policy on or before May 11, 2026, that will not prioritize enforcement against some flavored vapes and nicotine pouches sold without authorization. The policy applies if manufacturers have filed applications that were accepted by the FDA.
For flavored vapes, manufacturers must also have provided what the agency deems sufficient data to evaluate whether the product is appropriate for the protection of public health.
Under the new FDA policy, the agency does not have to complete its evaluation of the public health data for manufacturers to avoid enforcement. The FDA published the new guidance without first issuing a draft for public comment. Mitch Zeller, a former head of the Center for Tobacco Products at the FDA, said the FDA skipped the process of issuing a draft guidance and allowing public comments.
"It is alarming," Zeller said, because typically the FDA only goes straight to final guidance if there is a public health emergency. Zeller added that the new policy gives a get-out-of-jail-free card to companies that were selling without authorization. He said the policy is unfair to companies that followed the rules and kept their products off the market.
Zeller stated that selling products without FDA permission is illegal. The FDA last week authorized two fruit-flavored vapes produced by Glas, a company based in Los Angeles. That authorization reversed a previous decision by Commissioner Marty Makary.
Marty Makary told STAT he had been skeptical that the Glas devices’ technology would be enough to stop underage people from using them. Illicit e-cigarettes imported from China make up about 70% of the black market. The new FDA policy does not address illegal flavored vapes imported from China.
President Trump reportedly plans to fire FDA commissioner Marty Makary. Sarah Todd is a Reporter covering Commercial Determinants of Health for STAT and returned to reporting in January 2025.
Key Facts
Story Timeline
3 events- 2026-05-11
FDA announces new enforcement policy on unauthorized flavored vapes and nicotine pouches without issuing draft for public comment
3 sourcesFDA · STAT · New York Times - 2026-05-04 to 2026-05-10
FDA authorizes two fruit-flavored vapes from Los Angeles-based Glas, reversing prior decision by Commissioner Marty Makary
1 sourceFDA - 2026-01-01
Sarah Todd returns to reporting at STAT after serving as assignment editor
1 sourceSTAT
Potential Impact
- 01
Manufacturers who sold without authorization may continue sales while applications are pending
- 02
Companies that complied by withholding products face competitive disadvantage
- 03
Enforcement focus likely shifts toward illicit imports from China making up 70% of black market
- 04
Potential increase in flavored vape availability in retail stores
Transparency Panel
Related Stories
NprWHO Director Visits Congo as Ebola Outbreak Spreads
The head of the World Health Organization arrived in Kinshasa to support efforts against a rare Ebola strain. Health workers face equipment shortages, community distrust, and armed conflict in affected provinces.
medpagetoday.comFDA Panel Recommends XFG Variant for Fall Covid Shots
Replimune will submit an application to the FDA for the third time. Pfizer and Innovent Biologics reached a collaboration agreement valued at up to $10.5 billion.
Benzinga Publishes Article on Biotech Stocks During Pandemic Recovery
Benzinga published an article titled 'Best Biotech Stocks Right Now' that addresses the sector's position during global recovery from the pandemic. The piece notes government institutions and professional traders are focusing on biotech companies for vaccine and booster developme…